Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
109.70
+0.14 (0.13%)
Jun 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 109.01 - 109.89
52 week 77.29 - 110.38
Open 109.66
Vol / Avg. 0.00/817,662.00
Mkt cap 15.03B
P/E 21.96
Div/yield 0.45/1.64
EPS 5.00
Shares 136.83M
Beta 0.72
Inst. own 93%
Jul 25, 2017
Q2 2017 Quest Diagnostics Inc Earnings Release - 9:30AM EDT - Add to calendar
Jul 25, 2017
Q2 2017 Quest Diagnostics Inc Earnings Call Add to calendar
May 23, 2017
Quest Diagnostics Inc at UBS Global Healthcare Conference - Webcast
May 16, 2017
Quest Diagnostics Inc Annual Shareholders Meeting
May 3, 2017
Quest Diagnostics Inc at Deutsche Bank Health Care Conference - Webcast
Apr 20, 2017
Q1 2017 Quest Diagnostics Inc Earnings Release
Apr 20, 2017
Q1 2017 Quest Diagnostics Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 9.22% 9.26%
Operating margin 14.69% 16.99%
EBITD margin - 20.13%
Return on average assets 6.95% 6.94%
Return on average equity 14.21% 13.79%
Employees 43,000 -
CDP Score - C

Address

3 Giralda Farms
MADISON, NJ 07940
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Officers and directors

Stephen H. Rusckowski Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
James E. Davis Executive Vice President, General Diagnostics
Age: 54
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Group Executive - Diagnostic Solutions
Age: 62
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 50
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing
Age: 54
Bio & Compensation  - Reuters
Carrie Eglinton Manner Senior Vice President - Advanced Diagnostics
Age: 42
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Lead Independent Director
Age: 71
Bio & Compensation  - Reuters
Jenne K. Britell Ph.D. Independent Director
Age: 74
Bio & Compensation  - Reuters